Molecular mechanisms of anti-tumor properties of P276-00 in head and neck squamous cell carcinoma

BACKGROUND: Tumors of the head and neck present aggressive pathological behavior in patients due to high expression of CDK/CCND1 proteins. P276-00, a novel CDK inhibitor currently being tested in clinic, inhibits growth of several cancers in vitro and in vivo. The pre clinical activity of P276-00 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Prabha B, Lobo, Aurelio S, Joshi, Kalpana S, Rathos, Maggie J, Kumar, Gopinath A, Padigaru, Muralidhara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672051/
https://www.ncbi.nlm.nih.gov/pubmed/23414419
http://dx.doi.org/10.1186/1479-5876-11-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672051/
https://www.ncbi.nlm.nih.gov/pubmed/23414419
http://dx.doi.org/10.1186/1479-5876-11-42

Ejemplares similares